查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375995

初级保健 POC 诊断市场规模、份额、趋势分析报告：按产品、最终用途、地区和细分市场分類的趋势，2023-2030 年

Primary Care POC Diagnostics Market Size, Share & Trends Analysis Report By Product (Glucose Testing, Lipid Testing, Drug Abuse Testing), By End-use (Pharmacy & Retail Clinics, Physician Office), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 192 Pages | 商品交期: 2-10个工作天内

价格

初级保健 POC 诊断市场成长和趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球初级保健POC诊断市场规模预计将达到261.7亿美元，预测期内年复合成长率为6.5%。

我们灵活且先进的核心分子实验室支援并支援使用 POC 测试，将许多常见目标的筛检转移到医院接待室和医生办公室。

根据《美国临床病理学杂誌》2014 年进行的一项研究，POC 检测的效果优于製造商，患者的随访电话和信件分别减少了 85.0% 和 89.0%，随访减少了 61.0%。被发现可以改善临床业务。此外，测试订单数量下降了21.0%。

此外，根据 1988 年临床实验室改进法案 (CLIA) 获得豁免状态的检测数量不断增加预计将推动市场成长。由于每位患者的成本节省约 12-15 美元，后续检测减少约 50.0%，研究机构和製造商越来越多地推荐这些检测。然而，不同的测试方法及其使用领域之间存在显着的重迭。例如，血糖检测板和快速国际标准化比率测试最初用于自我测试，现在已在医院和初级机构中使用。

初级保健 POC 诊断市场报告亮点

  • 2022年，由于感染疾病不断上升、对快速准确诊断的需求以及对POC检测益处的认识不断增强，感染疾病行业占据最大的市场占有率，达到26.4%。
  • 将血脂检测作为常规检查一部分的门诊诊所的增加，预计将积极提高血脂检测在市场上的采用率，并使其在整个市场的产品中占据显着地位。
  • 就最终用途而言，研究机构和生物技术公司对先进、更准确的 POC检测套组的合作探索可能会推动医生办公室领域的发展，而政府扩大初级保健设施的倡议和计划预计将推动非诊所领域的发展诊所部分。
  • 北美的初级保健 POC 诊断市场比世界其他地区更加发达。该地区的发展得益于多种创新和先进的 POC 诊断产品的推出，以及初级家庭医疗保健和辅助医学中对 POC 诊断的认识和需求的不断增长。
  • 美国市场的患者越来越多地参与居家医疗、家庭测试和监测设备。此外，基于网路的数位化、电子病历、远端医疗和监测资料解决方案在美国正在加速发展并推动成长。

目录

第1章调查方法与范围

第2章执行摘要

第3章初级保健 POC 诊断市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 初级保健 POC 诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章初级保健 POC 诊断：产品估算/趋势分析

  • 初级保健 POC 诊断市场：要点
  • 初级保健 POC 诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 血糖测试
    • 2018年至2030年血糖检测市场估计与预测
  • Hb1Ac 测试
    • 2018 年至 2030 年 Hb1Ac 检测市场估计与预测
  • 自体免疫疾病
    • 2018年至2030年自体免疫疾病市场估计与预测
  • 凝固
    • 2018年至2030年混凝市场估计与预测
  • 生育力
    • 2018年至2030年不孕市场估计与预测
  • 感染疾病
    • 2018年至2030年感染疾病市场估计与预测
  • 心臟标记
    • 2018年至2030年心臟标记物市场估计与预测
  • 甲状腺刺激素
    • 2018年至2030年甲状腺刺激素市场估计与预测
  • 血液学
    • 2018年至2030年血液学市场估计与预测
  • 初级保健系统
    • 2018年至2030年初级保健系统市场估计与预测
  • 分散式临床化学
    • 2018年至2030年分散式临床化学市场估计与预测
  • 屎
    • 2018年至2030年粪便市场估计与预测
  • 血脂测试
    • 2018年至2030年血脂检测市场估计与预测
  • 癌症标记物
    • 2018年至2030年癌症标记物市场估计与预测
  • 血气/电解质
    • 2018 年至 2030 年血气/电解质市场估计与预测
  • 门诊化学
    • 2018年至2030年门诊化学品市场估计与预测
  • 药物滥用测试
    • 2018年至2030年药物滥用检测市场估计与预测
  • 尿液检查
    • 2018年至2030年尿液检查市场估计与预测

第5章初级保健 POC 诊断：最终用途估计和趋势分析

  • 初级保健 POC 诊断市场：要点
  • 初级保健 POC 诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 药房和零售诊所
  • 诊所
  • 紧急医疗诊所
  • 非医疗诊所

第6章初级保健POC诊断市场：区域估计与趋势分析

  • 区域展望
  • 按地区分類的初级保健 POC 诊断市场：主要市场点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • F Hoffmann-La Roche Ltd.
    • Danaher
    • Abbott
    • Siemens Healthineers
    • bioMerieux SA
    • Abaxis
    • QIAGEN
    • Johnson & Johnson Services, Inc.
    • Nova Biomedical
    • Instrumentation Laboratory
    • Trividia Health, Inc.
    • OraSure Technologies, Inc.
    • Quidel Corporation
    • Trinity Biotech
    • Sekisui Diagnostics
    • BD
Product Code: GVR-2-68038-333-1

Primary Care POC Diagnostics Market Growth & Trends:

The global primary care POC diagnostics market size is expected to reach USD 26.17 billion by 2030, according to a new report by Grand View Research, Inc.., registering a 6.5% CAGR during the forecast period. Flexible and forward-thinking core molecular labs have been embracing and supporting the use of POC tests to move screening of many common targets to hospital receiving rooms and physicians' offices.

As per a study conducted by the American Journal of Clinical Pathology in 2014, it was found that POC testing improved clinical operations for manufacturers by reducing follow-up calls and letters of patients by 85.0% and 89.0%, respectively, and reducing their follow-up visits by 61.0%. It was also observed that the number of tests ordered decreased by 21.0%.

Furthermore, rise in the number of tests receiving a waived status under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) is anticipated to aid market growth. Researchers and manufacturers are increasingly recommending these tests owing to cost reduction of about USD 12-15 per patient and reduction in follow up tests by about 50.0%. However, there is a massive overlap between different methods and their areas of usage. For instance, panels to measure glucose and quick international normalized ratio tests were originally meant for self-testing but are now used in hospitals and primary settings instead.

Primary Care POC Diagnostics Market Report Highlights:

  • The infectious disease segment held the largest market share at 26.4% in 2022, owing to the increased prevalence of infectious diseases, demand for quick and precise diagnosis, and the growing awareness of the benefits of POC testing.
  • Increase in out-patient practices for lipid testing as part of a routine checkup is expected to positively enhance the adoption rate of lipid testing in the market, giving it a prominent spot in the overall market by product
  • In terms of end use, while collaborative research for advanced and more accurate POC testing kits by research institutes and biotech firms is likely to facilitate the physicians' office segment, government initiatives and projects to extend primary care facilities will boost the non-practice clinics segment
  • The North America primary care POC diagnostics market is more developed compared to the rest of the world. The regional segment is fueled by availability of several innovative and advanced POC diagnostic products and growing awareness and demand for point-of-care diagnostics in primary home healthcare and assisted healthcare
  • The U.S. market is witnessing a shift toward increasing patient involvement in home care, home-based tests, and monitoring instruments. In addition, digitalization, EHR, telemedicine, and web-enabled solutions of monitoring data are gaining pace in U.S., thereby driving its growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Primary Care POC Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Primary Care POC Diagnostics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Primary Care POC Diagnostics: Product Estimates & Trend Analysis

  • 4.1. Primary Care POC Diagnostics Market: Key Takeaways
  • 4.2. Primary Care POC Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Glucose Testing
    • 4.3.1. Glucose Testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Hb1Ac Testing
    • 4.4.1. Hb1Ac testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. 4.5. Autoimmune Disease
    • 4.5.1. Autoimmune Disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Coagulation
    • 4.6.1. Coagulation market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Fertility
    • 4.7.1. Fertility market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Infectious Diseases
    • 4.8.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Cardiac Markers
    • 4.9.1. Cardiac markers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. Thyroid Stimulating Hormone
    • 4.10.1. Thyroid stimulating hormone market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.11. Hematology
    • 4.11.1. Hematology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.12. Primary Care Systems
    • 4.12.1. Primary care systems market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.13. Decentralized Clinical Chemistry
    • 4.13.1. Decentralized clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.14. Feces
    • 4.14.1. Feces market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.15. Lipid Testing
    • 4.15.1. Lipid testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.16. Cancer Markers
    • 4.16.1. Cancer markers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.17. Blood Gas/Electrolytes
    • 4.17.1. Blood gas/electrolytes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.18. Ambulatory Chemistry
    • 4.18.1. Ambulatory chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.19. Drug Abuse Testing
    • 4.19.1. Drug abuse testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.20. Urinalysis
    • 4.20.1. Urinalysis market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Primary Care POC Diagnostics: End Use Estimates & Trend Analysis

  • 5.1. Primary Care POC Diagnostics Market: Key Takeaways
  • 5.2. Primary Care POC Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Pharmacy & Retail Clinics
    • 5.3.1. Pharmacy & Retail Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Physician office
    • 5.4.1. Physician office market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Urgent Care Clinics
    • 5.5.1. Urgent care clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Non-practice Clinics
    • 5.6.1. Non-practice clinics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Primary Care POC Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Primary Care POC Diagnostics Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. F Hoffmann-La Roche Ltd.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Danaher
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Abbott
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Siemens Healthineers
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. bioMerieux SA
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Abaxis
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. QIAGEN
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Johnson & Johnson Services, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Nova Biomedical
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Instrumentation Laboratory
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Trividia Health, Inc.
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. OraSure Technologies, Inc.
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Quidel Corporation
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Trinity Biotech
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives
    • 7.2.15. Sekisui Diagnostics
      • 7.2.15.1. Company overview
      • 7.2.15.2. Financial performance
      • 7.2.15.3. Product benchmarking
      • 7.2.15.4. Strategic initiatives
    • 7.2.16. BD
      • 7.2.16.1. Company overview
      • 7.2.16.2. Financial performance
      • 7.2.16.3. Product benchmarking
      • 7.2.16.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 10 Europe primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 15 UK primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 17 France primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Sweden primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 23 Sweden primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Norway primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 25 Norway primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Denmark primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 27 Denmark primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 31 China primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 32 China primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Japan primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 34 Japan primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 36 India primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Australia primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Australia primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Thailand primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 40 Thailand primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 41 South Korea primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 42 South Korea primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa primary care POC diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait primary care POC diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait primary care POC diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Primary care POC diagnostics: Market outlook
  • Fig. 9 Primary care POC diagnostics: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Primary care POC diagnostics market driver impact
  • Fig. 15 Primary care POC diagnostics market restraint impact
  • Fig. 16 Primary care POC diagnostics market strategic initiatives analysis
  • Fig. 17 Primary care POC diagnostics market: Product movement analysis
  • Fig. 18 Primary care POC diagnostics market: Product outlook and key takeaways
  • Fig. 19 Glucose testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Hb1Ac testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Autoimmune disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Coagulation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Fertility market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Infectious diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Cardiac markers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Thyroid stimulating hormone market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Hematology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Primary care systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Decentralized clinical chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Feces market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Lipid testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Cancer Marker market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Blood gas/electrolytes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Ambulatory chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Drug abuse testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Urinalysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Primary care POC diagnostics market: End use movement analysis
  • Fig. 38 Primary care POC diagnostics market: End use outlook and key takeaways
  • Fig. 39 Pharmacy & retail clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Physician office market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Urgent care clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Non-practice clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Global primary care POC diagnostics market: Regional movement analysis
  • Fig. 44 Global primary care POC diagnostics market: Regional outlook and key takeaways
  • Fig. 45 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)